What Researchers Did
Researchers conducted a randomized clinical trial in Brazil to see if hyperbaric oxygen therapy, given at 2.3 atmospheres absolute for 90 minutes, five times a week over 8 weeks, improved symptoms for women with fibromyalgia.
What They Found
The abstract for this study details the design and methods used to evaluate hyperbaric oxygen therapy for fibromyalgia. It describes a randomized, cross-over trial involving 56 women, but it does not present any specific findings, numbers, or outcomes from the research.
Canadian Relevance
This study was conducted in Brazil and does not include Canadian authors or participants. Fibromyalgia is not a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection identified.
Study Limitations
A limitation of this study is that it was conducted at a single centre, which may affect how broadly the findings can be applied to other populations.